Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4667249> ?p ?o }
Showing triples 1 to 27 of
27
with 100 triples per page.
- Q4667249 subject Q7427150.
- Q4667249 subject Q8297708.
- Q4667249 subject Q8431759.
- Q4667249 subject Q8515266.
- Q4667249 subject Q8805811.
- Q4667249 abstract "Abexinostat (INN, formerly PCI-24781) is an experimental drug candidate for cancer treatment. It is currently under development by Pharmacyclics and is in Phase II clinical trials for B-cell lymphoma. Pre-clinical study suggests the potential for treatment of different types of cancer as well.Abexinostat exerts its effect as a histone deacetylase inhibitor.".
- Q4667249 iupacName "3-[(Dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide".
- Q4667249 thumbnail Abexinostat.svg?width=300.
- Q4667249 wikiPageWikiLink Q2198549.
- Q4667249 wikiPageWikiLink Q3569101.
- Q4667249 wikiPageWikiLink Q420060.
- Q4667249 wikiPageWikiLink Q4833719.
- Q4667249 wikiPageWikiLink Q7427150.
- Q4667249 wikiPageWikiLink Q824258.
- Q4667249 wikiPageWikiLink Q8297708.
- Q4667249 wikiPageWikiLink Q8431759.
- Q4667249 wikiPageWikiLink Q8515266.
- Q4667249 wikiPageWikiLink Q8805811.
- Q4667249 iupacname "3".
- Q4667249 type ChemicalCompound.
- Q4667249 type ChemicalSubstance.
- Q4667249 type ChemicalObject.
- Q4667249 type Thing.
- Q4667249 type Q11173.
- Q4667249 comment "Abexinostat (INN, formerly PCI-24781) is an experimental drug candidate for cancer treatment. It is currently under development by Pharmacyclics and is in Phase II clinical trials for B-cell lymphoma. Pre-clinical study suggests the potential for treatment of different types of cancer as well.Abexinostat exerts its effect as a histone deacetylase inhibitor.".
- Q4667249 label "Abexinostat".
- Q4667249 depiction Abexinostat.svg.